282 related articles for article (PubMed ID: 33807419)
1. Molecular Mechanisms of Canine Osteosarcoma Metastasis.
Wilk SS; Zabielska-Koczywąs KA
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33807419
[TBL] [Abstract][Full Text] [Related]
2. ΔNp63 mediates cellular survival and metastasis in canine osteosarcoma.
Cam M; Gardner HL; Roberts RD; Fenger JM; Guttridge DC; London CA; Cam H
Oncotarget; 2016 Jul; 7(30):48533-48546. PubMed ID: 27391430
[TBL] [Abstract][Full Text] [Related]
3. Effects of transplantation sites on tumour growth, pulmonary metastasis and ezrin expression of canine osteosarcoma cell lines in nude mice.
Jaroensong T; Endo Y; Lee SJ; Kamida A; Mochizuki M; Nishimura R; Sasaki N; Nakagawa T
Vet Comp Oncol; 2012 Dec; 10(4):274-82. PubMed ID: 22236104
[TBL] [Abstract][Full Text] [Related]
4. Ezrin and moesin expression in canine and feline osteosarcoma.
Hlavaty J; Wolfesberger B; Hauck M; Obermayer-Pietsch B; Fuchs-Baumgartinger A; Miller I; Walter I
Histol Histopathol; 2017 Aug; 32(8):805-816. PubMed ID: 27900754
[TBL] [Abstract][Full Text] [Related]
5. MiR-34a regulates the invasive capacity of canine osteosarcoma cell lines.
Lopez CM; Yu PY; Zhang X; Yilmaz AS; London CA; Fenger JM
PLoS One; 2018; 13(1):e0190086. PubMed ID: 29293555
[TBL] [Abstract][Full Text] [Related]
6. Characterization of STAT3 activation and expression in canine and human osteosarcoma.
Fossey SL; Liao AT; McCleese JK; Bear MD; Lin J; Li PK; Kisseberth WC; London CA
BMC Cancer; 2009 Mar; 9():81. PubMed ID: 19284568
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase C regulates ezrin-radixin-moesin phosphorylation in canine osteosarcoma cells.
Hong SH; Osborne T; Ren L; Briggs J; Mazcko C; Burkett SS; Khanna C
Vet Comp Oncol; 2011 Sep; 9(3):207-18. PubMed ID: 21848623
[TBL] [Abstract][Full Text] [Related]
8. Oncostatin M promotes STAT3 activation, VEGF production, and invasion in osteosarcoma cell lines.
Fossey SL; Bear MD; Kisseberth WC; Pennell M; London CA
BMC Cancer; 2011 Apr; 11():125. PubMed ID: 21481226
[TBL] [Abstract][Full Text] [Related]
9. Canine osteosarcoma: a naturally occurring disease to inform pediatric oncology.
Fenger JM; London CA; Kisseberth WC
ILAR J; 2014; 55(1):69-85. PubMed ID: 24936031
[TBL] [Abstract][Full Text] [Related]
10. MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines.
Fenger JM; Roberts RD; Iwenofu OH; Bear MD; Zhang X; Couto JI; Modiano JF; Kisseberth WC; London CA
BMC Cancer; 2016 Oct; 16(1):784. PubMed ID: 27724924
[TBL] [Abstract][Full Text] [Related]
11. The actin-cytoskeleton linker protein ezrin is regulated during osteosarcoma metastasis by PKC.
Ren L; Hong SH; Cassavaugh J; Osborne T; Chou AJ; Kim SY; Gorlick R; Hewitt SM; Khanna C
Oncogene; 2009 Feb; 28(6):792-802. PubMed ID: 19060919
[TBL] [Abstract][Full Text] [Related]
12. Role of ezrin in osteosarcoma metastasis.
Ren L; Khanna C
Adv Exp Med Biol; 2014; 804():181-201. PubMed ID: 24924175
[TBL] [Abstract][Full Text] [Related]
13. Met interacts with EGFR and Ron in canine osteosarcoma.
McCleese JK; Bear MD; Kulp SK; Mazcko C; Khanna C; London CA
Vet Comp Oncol; 2013 Jun; 11(2):124-39. PubMed ID: 22235915
[TBL] [Abstract][Full Text] [Related]
14. Expression of hepatocyte growth factor and the proto-oncogenic receptor c-Met in canine osteosarcoma.
Fieten H; Spee B; Ijzer J; Kik MJ; Penning LC; Kirpensteijn J
Vet Pathol; 2009 Sep; 46(5):869-77. PubMed ID: 19429984
[TBL] [Abstract][Full Text] [Related]
15. HES1, a target of Notch signaling, is elevated in canine osteosarcoma, but reduced in the most aggressive tumors.
Dailey DD; Anfinsen KP; Pfaff LE; Ehrhart EJ; Charles JB; Bønsdorff TB; Thamm DH; Powers BE; Jonasdottir TJ; Duval DL
BMC Vet Res; 2013 Jul; 9():130. PubMed ID: 23816051
[TBL] [Abstract][Full Text] [Related]
16. Investigating CXCR4 expression in canine appendicular osteosarcoma.
Fan TM; Barger AM; Fredrickson RL; Fitzsimmons D; Garrett LD
J Vet Intern Med; 2008; 22(3):602-8. PubMed ID: 18466248
[TBL] [Abstract][Full Text] [Related]
17. An evaluation of TAZ and YAP crosstalk with TGFβ signalling in canine osteosarcoma suggests involvement of hippo signalling in disease progression.
Luu AK; Schott CR; Jones R; Poon AC; Golding B; Hamed R; Deheshi B; Mutsaers A; Wood GA; Viloria-Petit AM
BMC Vet Res; 2018 Nov; 14(1):365. PubMed ID: 30477496
[TBL] [Abstract][Full Text] [Related]
18. Expression profiling in canine osteosarcoma: identification of biomarkers and pathways associated with outcome.
O'Donoghue LE; Ptitsyn AA; Kamstock DA; Siebert J; Thomas RS; Duval DL
BMC Cancer; 2010 Sep; 10():506. PubMed ID: 20860831
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of metastatic osteosarcoma: Differentially expressed genes, transcription factors and microRNAs.
Heng L; Jia Z; Bai J; Zhang K; Zhu Y; Ma J; Zhang J; Duan H
Mol Med Rep; 2017 May; 15(5):2829-2836. PubMed ID: 28260111
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance and in vitro cellular regulation of hypoxia mimicry on HIF-1α and downstream genes in canine appendicular osteosarcoma.
Gola C; Iussich S; Noury S; Martano M; Gattino F; Morello E; Martignani E; Maniscalco L; Accornero P; Buracco P; Aresu L; De Maria R
Vet J; 2020 Oct; 264():105538. PubMed ID: 33012439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
